Nerve sprouting suppresses myocardial I(to) and I(K1) channels and increases severity to ventricular fibrillation in rat

Auton Neurosci. 2008 Dec 15;144(1-2):22-9. doi: 10.1016/j.autneu.2008.08.004. Epub 2008 Sep 25.

Abstract

Nerve sprouting in healed myocardial infarction has been associated with increased incidences of ventricular tachyarrhythmia and sudden cardiac death. However, the underlying electrophysiological mechanisms are unclear. To investigate the linkage between nerve sprouting and potassium channel function, we developed a rat model of cardiac sympathetic nerve sprouting by chronic subcutaneous injection of 4-methylcatechol, a potent stimulator of nerve growth factor (NGF) synthesis. Cardiac sympathetic nerves were visualized by immunohistochemical staining. Myocardial necrotic injury was created by focal cold shock across intact diaphragm to mimic infarction. Transient outward current (I(to)) and inward rectifier current (I(K1)) of cardiomyocytes were recorded with the whole-cell patch clamp technique. We found that chronic 4-MC administration 1) increased cardiac NGF level and the density of cardiac sympathetic innervation; 2) decreased the expressions of Kv4.2, Kv channel-interacting protein 2 (KChIP2), Kir2.1, and the current densities of I(to) and I(K1); 3) reduced the phosphorylation of extracellular signal-regulated kinase 1/2 (pERK1/2); and 4) decreased heart rate variability and increased the susceptibility to ventricular fibrillation. Myocardial necrotic injury exerted similar effects as 4-methylcatechol, and 4-methylcatechol plus myocardial necrotic injury intensified the cardiac effects of 4-methylcatechol alone and decreased the phosphoralation of cAMP response element-binding protein (CREB). We conclude that nerve sprouting suppressed the expressions and functions of myocardial I(to) and I(K1) channels and increased the susceptibility to ventricular fibrillation. These effects are associated with decreased phosphorylation of ERK and CREB and reduced expression of KChIP2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catechols / pharmacology
  • Cyclic AMP Response Element-Binding Protein / drug effects
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Disease Models, Animal
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Growth Cones / drug effects
  • Growth Cones / metabolism
  • Growth Cones / ultrastructure
  • Kv Channel-Interacting Proteins / drug effects
  • Kv Channel-Interacting Proteins / metabolism
  • Male
  • Myocardial Infarction / complications*
  • Nerve Growth Factor / agonists
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology*
  • Neuroprotective Agents / pharmacology
  • Phosphorylation / drug effects
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism*
  • Potassium Channels, Inwardly Rectifying / drug effects
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Rats
  • Rats, Wistar
  • Shal Potassium Channels / drug effects
  • Shal Potassium Channels / metabolism
  • Sympathetic Fibers, Postganglionic / drug effects
  • Sympathetic Fibers, Postganglionic / metabolism
  • Sympathetic Fibers, Postganglionic / physiopathology*
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / metabolism
  • Tachycardia, Ventricular / physiopathology*
  • Up-Regulation / drug effects
  • Up-Regulation / physiology
  • Ventricular Fibrillation / etiology
  • Ventricular Fibrillation / metabolism
  • Ventricular Fibrillation / physiopathology*

Substances

  • Catechols
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Kcnip2 protein, rat
  • Kir2.1 channel
  • Kv Channel-Interacting Proteins
  • Neuroprotective Agents
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Shal Potassium Channels
  • 4-methylcatechol
  • Nerve Growth Factor
  • Extracellular Signal-Regulated MAP Kinases